Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1193 of 5804
-
Desperate pancreatic cancer patients offered experimental Two-Drug combo
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety and efficacy of JDB153 combined with Serplulimab in patients with pancreatic cancer after standard treatment failure.
Phase: PHASE1, PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:52 UTC
-
New radiation regimen cuts treatment time for early glottic cancer
Disease control Not yet recruitingEarly-stage glottic carcinoma (T1-T2N0M0) is typically managed with either transoral laser microsurgery or definitive radiotherapy, both providing excellent local control rates and voice preservation outcomes. Radiotherapy remains a widely adopted non-invasive option, particularl…
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New pill hopes to tame ulcerative colitis in older adults
Disease control Recruiting nowEligible patients will be identified in regular clinical practice. After providing thorough explanation and obtaining voluntary written informed consent, the clinical course, adverse events, endoscopic findings, and histopathological changes in biopsy specimens after Etrasimod ad…
Phase: NA • Sponsor: Showa Inan General Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could a simple capsule beat chemo fatigue? new trial aims to find out
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate whether Nuvastatic 300 mg capsules can reduce cancer-related fatigue in adult patients with colon cancer undergoing first-line chemotherapy. The main questions it aims to answer are: * Does Nuvastatic 300 mg capsules significantly …
Phase: PHASE3 • Sponsor: Natureceuticals Sdn Bhd • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New stent aims to fix deadly aortic tear without open surgery
Disease control Not yet recruitingThis study is the feasible study on a new technique of ZIPPER aortic arch stentgraft system
Phase: NA • Sponsor: Hangzhou Endonom Medtech Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 17:27 UTC
-
New drug crisugabalin takes on pregabalin in fibromyalgia pain showdown
Symptom relief Recruiting nowFibromyalgia (FM) is a chronic pain syndrome characterized by widespread pain, fatigue, and emotional disorders. Its onset is related to factors such as central sensitization and imbalance of neurotransmitters. The current mainstream treatments include pregabalin, but the efficac…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Sound waves may unlock secrets of Treatment-Resistant depression
Knowledge-focused Recruiting nowApproximately one third of individuals with Major Depressive Disorder (MDD) are considered treatment-resistant, subject to severe disability and risk of suicide, and exhibit symptoms anchored in abnormalities of Research Domain Criteria (RDoC) Negative Valence Systems behavioral …
Phase: NA • Sponsor: Laureate Institute for Brain Research, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
New hope for breast cancer patients who stopped responding to standard therapy
Disease control Recruiting nowThis is a prospective, single-arm, single-center, Phase II clinical study designed to assess the preliminary efficacy and safety of SKB264 Plus Inetetamab plus inetetamab for the treatment of HER2-positive, unresectable, locally advanced or metastatic breast cancer following prog…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New hope for CRPS sufferers: brain zaps and therapy combo put to the test
Symptom relief Recruiting nowThe aim of the study is to investigate and improve non-pharmacological rehabilitation methods for patients with Complex Regional Pain Syndrome (CRPS) to reduce pain and restore work and functional capacity to lower overall treatment costs. Current treatment methods offer limited …
Phase: NA • Sponsor: Oulu University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New pill could help women stop leaking urine during exercise
Symptom relief Recruiting nowThe GZPS master protocol will support two independent studies, J2A-MC-GZS1 and J2A-MC-GZS2. Each study will see how well and safely orforglipron works in adult female participants with stress urinary incontinence (SUI) who have obesity or overweight. SUI is leaking urine during m…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
New weekly shot aims to tame type 2 diabetes
Disease control Not yet recruitingThe study is being conducted to evaluate the efficacy and safety of HS-20094 once weekly (QW) in subjects with type 2 diabetes mellitus not adequately controlled with metformin monotherapy or in combination with SGLT2 inhibitors compared to Dulaglutide QW for 44 weeks and 52 week…
Phase: PHASE3 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 13:37 UTC
-
New drug combo targets advanced cancers in Mid-Stage trial
Disease control Recruiting nowThis is an open-label, multicenter Phase II study of MHB036C combined with MHB039A in patients with advanced Breast Cancer or other advanced malignant solid tumors. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of MHB036C and MHB…
Phase: PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Shockwaves in your heart: new device zaps artery calcium
Disease control Recruiting nowInterventional cardiologists are facing an increasing burden of calcified coronary arteries in keeping with an ageing population and rising prevalence of diabetes mellitus and chronic kidney disease. Heavily calcified plaques impede balloon dilatation and successful stent deliver…
Phase: NA • Sponsor: National Heart Centre Singapore • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can friends help find hidden HIV? new trial recruits peers to boost testing
Knowledge-focused Recruiting nowIn South Africa's large generalized HIV epidemic, male-to-female transmission comprises a large proportion of transmission events, but men are much less likely to seek HIV testing, and disproportionately remain undiagnosed. HIV-related stigma is a key barrier to recruiting men to…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Can unresponsive patients still form memories? new study investigates
Knowledge-focused Recruiting nowFollowing severe brain damage, some individuals lose partial or total awareness of themselves and their environment, falling into a coma that can evolve towards a Disorder of Consciousness (DoC). Accurately diagnosing the depth of consciousness alteration, and thus characterizing…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
New drug mimics IVIg to fight low platelet disorder
Disease control Recruiting nowThe purpose of the study is to evaluate the safety of NVG-2089 and to evaluate how well patients respond to this investigational treatment. NVG-2089 is a new drug that is being developed for treating patients with ITP. NVG-2089 is designed to mimic the effects of a protein called…
Phase: PHASE2 • Sponsor: Nuvig Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New pill aims to melt liver fat in NASH patients
Disease control Recruiting nowThe goal of this clinical trial is to learn if CS060380 tablets works to treat non-alcoholic steatohepatitis(NASH) in adults.It will also learn about the safety of CS060380 tablets.The main questions it aims to answer are: * After 12 weeks of administration, what was the percent…
Phase: PHASE2 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Blood test may end misdiagnosis of bipolar disorder
Diagnosis Recruiting nowThe goal of this interventional clinical trial is to assess the diagnostic performance of a composite diagnostic medical devise based on blood-based in vitro diagnostic device and Mood Disorder Questionnaire (MDQ) in identifying bipolar disorder among adult patients presenting wi…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
New pill may shrink lung tumors before surgery in Gene-Mutated cancers
Disease control Not yet recruitingThis is a prospective, single-center phase II clinical study aimed at evaluating the efficacy and safety of Vebreltinib in neoadjuvant treatment for patients with resectable stage IIA-IIIB (N2) non-small cell lung cancer (NSCLC) with MET exon 14 skipping mutations. In the study, …
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 26, 2026 13:55 UTC
-
Could a hospital sedative fix PTSD nightmares?
Symptom relief CompletedPost-traumatic stress disorder (PTSD) affects many people who have experienced traumatic events. A common issue with PTSD is severe sleep disturbances, such as nightmares. Current treatments often do not provide sufficient relief, especially for sleep problems. This study aims to…
Phase: PHASE2 • Sponsor: Reconnect Labs • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC